Fig 1: Surface CD26 receptor expression levels on PBMCs of patient study groups. Isolated PBMCs of MERS-CoV patients (n = 20) and healthy controls (CTL) (n = 20) were collected. The cells (4 ×105) were distributed in each FACS tubes and stained with CD26-PE, CD4-PE-Cy7, CD8-APC, CD14-PerCp antibodies. The mean fluorescents intensity levels of CD26 on CD4+ T cells, CD8+ T cells, CD14+ monocytes from patients study groups was graphed.
Fig 2: Soluble CD66e and CD26 receptor expression levels in plasma of patient study groups. Plasma of MERS-CoV patients (n = 20) and healthy controls (CTL) (n = 20) were collected and soluble CD66e and CD26 receptors levels were analyzed using ELISA kits. (A) The mean levels of soluble CD66e receptor and CD26 receptor (B) and from patients study groups were graphed.
Supplier Page from Abcam for Human Dipeptidyl Peptidase IV ELISA Kit (CD26)